Top Ten most popular articles on Pharmafile.com this week
May 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …
Puma Biotech’s breast cancer drug gets FDA committee nod
May 25, 2017Medical Communications, Sales and Marketing Puma Biotech, breast cancer, neratinib
Puma Biotechnology breast cancer drug that could be used to reduce the risk of disease recurrence has been boosted by …
Pharmaceutical companies and patient advocacy groups: Natural allies in the support of patients
May 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Takeda oncology, patient advocacy
As published in the special Market Access section of the latest issue of Pharmafocus, Liz Lewis, Chief Counsel & Compliance …
Neurocrine’s Ingrezza flops in Tourette’s for second time
May 25, 2017Research and Development, Sales and Marketing Neurocrine Biosciences, tourette's
Neurocrine’s Tourette’s therapy Ingrezza (valbenazine) has been hit with yet another setback, flopping in a Phase 2 trial of paediatric …
Cannabidiol drug found to aid in devastating childhood epilepsy condition
May 25, 2017Research and Development GW Pharmaceuticals, cannabidoil, epilepsy
A treatment derived from cannabis has been found to produce remarkable results in children who have epilepsy. Cannabidoil, when offered …
Tedros Adhanom Ghebreyesus becomes WHO Director General
May 25, 2017Medical Communications WHO
Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
Inovio posts “exceptional” results for HIV vaccine
May 25, 2017Research and Development AIDS, HIV, HIV vaccine, Vaccine
Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …
26 die after attempting to replace Abbott’s blood pump controller themselves
May 24, 2017Medical Communications, Sales and Marketing Abbott, FDA, Medical device, deaths
At least 26 advanced heart failure patients have died and 19 have been injured by attempting to change the controller …
MSD receives first FDA approval based on specific genetic feature
May 24, 2017Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda
In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …
Antibiotics found to fail in quarter of pneumonia patients
May 24, 2017Research and Development Antibiotics, antibiotic resistance, pneumonia
A new study that emerged from the 2017 American Thoracic Society International Conference revealed that 22.1% of patients who were …
MSD under CMA investigation over unfair Remicade pricing
May 24, 2017Research and Development, Sales and Marketing Competition and Marketing Authority, MSD, Remicade
MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in …
Opioid crisis “highest initial priority” for new FDA Commissioner
May 24, 2017Medical Communications, Research and Development FDA, Scott Gottlieb, opioid, opioid crisis
Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently …
The June 2017 issue of Pharmafocus is now live!
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders
The latest edition of Pharmafocus is available to read online now!
European approval for novel Eisai epilepsy monotherapy
May 23, 2017Research and Development, Sales and Marketing Bial, Eisai, Zebinix, epilepsy
Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission …
Nativis Incorporated appoints new CSO
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis
Nativis, a clinical stage life science bio-clectronic company, has appointed Dr Kenneth Ferguson to the position of Chief Scientific Officer. …
Shortage of medicine made of kitchen basics hits US
May 23, 2017Manufacturing and Production Pfizer, Sodium bicarbonate
Do you have a pot of unused baking soda that sits at the back of the cupboard, forgotten? Well, hospitals …
Strong showing for AZ asthma drug, but diabetes treatment flops
May 23, 2017Manufacturing and Production, Research and Development AstraZeneca, asthma, diabetes
AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying …
U-turn performed over Conservative’s social care plans
May 23, 2017Manufacturing and Production, Medical Communications Conservative, Dementia tax, Election 2017, Jeremy Corbyn, Labour, Theresa May
One of the most controversial points of the Conservative’s was its social care plan. The plan would have seen those …
Sanofi and Regeneron score FDA approval for arthritis
May 23, 2017Manufacturing and Production, Sales and Marketing FDA, Kevzara, arthritis, sarilumab
The FDA has awarded Sanofi and Regeneron’s Kevzara (sarilumab) approval for the treatment of moderate to severely active rheumatoid arthritis …
EMA’s CHMP recommends Sanofi’s Humalog biosimilar
May 22, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Humalog, Sanofi
Sanofi has received a positive recommendation by the CHMP for its biosimilar to Eli Lilly’s Humalog. The recommendation for approval …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
